Adelaide Research & Scholarship: Search

Search

Results 1-10 of 33 (Search time: 0.002 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	Colorectal cancer treatment and survival : the experience of major public hospitals in South Australia over three decades	Roder, D.; Karapetis, C.; Wattchow, D.; Moore, J.; Singhal, N.; Joshi, R.; Keefe, D.; Fusco, K.; Powell, K.; Eckert, M.; Price, T.
	2014	The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17	Sommeijer, D.; Karapetis, C.; Zalcberg, J.; Tu, D.; Jonker, D.; Simes, J.; Tebbutt, N.; Yip, D.; Price, T.; O'Callaghan, C.
	2016	Fc-γ receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer	Liu, G.; Tu, D.; Lewis, M.; Cheng, D.; Sullivan, L.; Chen, Z.; Morgen, E.; Simes, J.; Price, T.; Tebbutt, N.; Shapiro, J.; Jeffery, G.; Mellor, J.; Mikeska, T.; Virk, S.; Shepherd, L.; Jonker, D.; O'Callaghan, C.; Zalcberg, J.; Karapetis, C.; et al.
	2016	Metastatic colorectal cancer in young adults: a study from the South Australian Population-Based Registry	Vatandoust, S.; Price, T.; Ullah, S.; Roy, A.; Beeke, C.; Young, J.; Townsend, A.; Padbury, R.; Roder, D.; Karapetis, C.
	2015	Metastatic colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades	Roder, D.; Karapetis, C.; Wattchow, D.; Moore, J.; Singhal, N.; Joshi, R.; Keefe, D.; Fusco, K.; Buranyi-Trevarton, D.; Sharplin, G.; Price, T.
	2014	Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer	Jonker, D.; Karapetis, C.; Harbison, C.; O'Callaghan, C.; Tu, D.; Simes, R.; Malone, D.; Langer, C.; Tebbutt, N.; Price, T.; Shapiro, J.; Siu, L.; Wong, R.; Bjarnason, G.; Moore, M.; Zalcberg, J.; Khambata-Ford, S.
	2013	Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?	Broadbridge, V.; Karapetis, C.; Beeke, C.; Woodman, R.; Padbury, R.; Maddern, G.; Kim, W.; Roder, D.; Hakendorf, P.; Price, T.
	2015	Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature	Chan, D.; Pavlakis, N.; Shapiro, J.; Price, T.; Karapetis, C.; Tebbutt, N.; Segelov, E.; Rosell, R.
	2015	Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies	Patel, G.; Ullah, S.; Beeke, C.; Hakendorf, P.; Padbury, R.; Price, T.; Karapetis, C.
	2014	Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies	Patel, G.; Jain, K.; Kumar, R.; Strickland, A.; Pellegrini, L.; Slavotinek, J.; Eaton, M.; McLeay, W.; Price, T.; Ullah, S.; Koczwara, B.; Kichenadasse, G.; Karapetis, C.